Medifast, Inc. MED
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -40.85M | -25.60M | -20.02M | -18.67M | 248.00K |
| Total Depreciation and Amortization | 12.76M | 13.85M | 14.45M | 14.24M | 13.96M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 33.29M | 21.14M | 19.25M | 21.10M | 1.39M |
| Change in Net Operating Assets | -5.22M | -591.00K | -9.95M | -9.81M | -8.41M |
| Cash from Operations | -26.00K | 8.79M | 3.72M | 6.86M | 7.19M |
| Capital Expenditure | -3.84M | -4.78M | -5.19M | -5.61M | -6.55M |
| Sale of Property, Plant, and Equipment | 3.64M | 3.64M | 3.64M | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -39.93M | -36.46M | -21.46M | -2.31M | -15.86M |
| Cash from Investing | -40.14M | -37.60M | -23.01M | -7.93M | -22.41M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.00K | 1.00K | 1.00K | 1.00K | 0.00 |
| Repurchase of Common Stock | -825.00K | -814.00K | -815.00K | -370.00K | -371.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -170.00K | -170.00K | -88.00K | -195.00K | -195.00K |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -994.00K | -983.00K | -902.00K | -564.00K | -566.00K |
| Foreign Exchange rate Adjustments | 4.00K | 4.00K | 4.00K | 4.00K | 0.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -41.15M | -29.78M | -20.19M | -1.63M | -15.78M |